• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[吡贝地尔在帕金森病早期和晚期的应用]

[The use of piribedil in early and late stages of Parkinson's disease].

作者信息

Fedorova N V, Kulua T K, Gubanova Е N

机构信息

Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia; Center of Extrapyramidal Disorders, Moscow.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):96-98. doi: 10.17116/jnevro201511510196-98.

DOI:10.17116/jnevro201511510196-98
PMID:26525631
Abstract

In this article, we present clinical cases at an early stage of Parkinson's disease with mild affective and cognitive disorders, and at a later stage with motor fluctuations and levodopa-induced dyskinesia. The efficacy of dopamine receptor agonists in treatment of Parkinson's disease in the early and late stages is illustrated by the example of piribedil.

摘要

在本文中,我们展示了帕金森病早期伴有轻度情感和认知障碍的临床病例,以及晚期出现运动波动和左旋多巴诱导的异动症的临床病例。以吡贝地尔为例说明了多巴胺受体激动剂在帕金森病早期和晚期治疗中的疗效。

相似文献

1
[The use of piribedil in early and late stages of Parkinson's disease].[吡贝地尔在帕金森病早期和晚期的应用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):96-98. doi: 10.17116/jnevro201511510196-98.
2
[Treatment of Parkinson's disease: use of piribedil].[帕金森病的治疗:吡贝地尔的应用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(1):54-6.
3
[The role of dopaminagonists in the treatment of Parkinson's disease].[多巴胺激动剂在帕金森病治疗中的作用]
Praxis (Bern 1994). 2005 Oct 19;94(42):1633-8. doi: 10.1024/0369-8394.94.42.1633.
4
[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].[普诺安(吡贝地尔)在帕金森病中的应用:一项多中心研究结果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(11):21-4.
5
[The agonist of dopamine receptors piribedil in treatment of Parkinson's disease].多巴胺受体激动剂吡贝地尔治疗帕金森病
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):83-90. doi: 10.17116/jnevro20171176183-90.
6
[The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].[吡贝地尔作为帕金森病患者左旋多巴辅助治疗的有效性和耐受性:九个月随访]
Rev Neurol. 2004;38(8):715-9.
7
Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias.多巴胺激动剂早期单一疗法用于延缓左旋多巴诱导的运动障碍的发生。
Expert Rev Neurother. 2015 Feb;15(2):207-13. doi: 10.1586/14737175.2015.1001747. Epub 2015 Jan 12.
8
Therapeutic strategies to prevent motor complications in Parkinson's disease.预防帕金森病运动并发症的治疗策略。
J Neurol. 2008 Aug;255 Suppl 4:42-5. doi: 10.1007/s00415-008-4007-4.
9
The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.多巴胺激动剂吡贝地尔与左旋多巴联用可改善注意力功能障碍:对帕金森病的意义。
J Pharmacol Exp Ther. 2006 Nov;319(2):914-23. doi: 10.1124/jpet.106.109207. Epub 2006 Aug 18.
10
Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.帕金森病的初始治疗:左旋多巴与多巴胺受体激动剂
J Neurol. 2002 Sep;249 Suppl 2:II25-9. doi: 10.1007/s00415-002-1205-3.